Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
60%
Ph phase_3
2
40%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (60.0%)
Phase 32 (40.0%)

Trials by Status

completed480%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_3

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

NCT02860624
completedphase_2

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients

NCT02847455
unknownphase_2

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

NCT01107938
completedphase_3

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)

NCT00952978
completedphase_2

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)

NCT00953381

Clinical Trials (5)

Showing 5 of 5 trials
NCT02860624Phase 3

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

Completed
NCT02847455Phase 2

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients

Completed
NCT01107938Phase 2

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

Unknown
NCT00952978Phase 3

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)

Completed
NCT00953381Phase 2

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5